Employing Human Induced Pluripotent Stem Cells (hiPSCs) to Model NF1-Associated Low Grade Gliomas by Hartigan, Kelly
Washington University in St. Louis 
Washington University Open Scholarship 
Volume 13 Washington University Undergraduate Research Digest 
Spring 2018 
Employing Human Induced Pluripotent Stem Cells (hiPSCs) to 
Model NF1-Associated Low Grade Gliomas 
Kelly Hartigan 
Washington University in St. Louis 
Follow this and additional works at: https://openscholarship.wustl.edu/wuurd_vol13 
Recommended Citation 
Hartigan, Kelly, "Employing Human Induced Pluripotent Stem Cells (hiPSCs) to Model NF1-Associated 
Low Grade Gliomas" (2018). Volume 13. 79. 
https://openscholarship.wustl.edu/wuurd_vol13/79 
This Abstracts A-I is brought to you for free and open access by the Washington University 
Undergraduate Research Digest at Washington University Open Scholarship. It has been accepted for inclusion in 
Volume 13 by an authorized administrator of Washington University Open Scholarship. For more information, 
please contact digital@wumail.wustl.edu. 
125
Toward a Better Understanding of...
Employing Human Induced Pluripotent 
Stem Cells (hiPSCs) to Model NF1-Associated 
Low Grade Gliomas
Kelly Hartigan
Mentor: David Gutmann
Neurofibromatosis type 1 (NF1) is a clinically heterogeneous cancer predisposition 
syndrome caused by a germline mutation in one of the two alleles of the NF1 gene. Low 
grade gliomas (LGGs), particularly in the optic pathway, are common in patients with NF1 
(15-20%). These tumors arise when the remaining allele is somatically inactivated in glial 
progenitor cells. Nf1 genetically-engineered mouse (GEM) models have been employed 
to study NF1-associated LGGs; however, there are still a limited number of therapeutic 
targets available. This lack of clinical translation could reflect species-specific differences 
between rodents and humans or the use of “knockout” mutations in the mouse models, 
whereas patients with NF1 harbor a diverse number of germline NF1 gene mutations. To 
study the importance of the germline mutation to LGG development and progression 
in human cells, the Gutmann Laboratory has created a collection of human induced 
pluripotent stem cells (hiPSCs) with NF1 patient mutations and hiPSC-derived cerebral 
organoids. Using this resource, we have generated mixed cerebral organoids comprised 
of hiPSCs homozygous for patient-specific NF1 mutations and hiPSCs heterozygous for 
distinct NF1 mutations spanning the NF1 gene. Our preliminary results demonstrate 
that these mixed organoid cultures exhibit histological characteristics of NF1-LGGs. 
Future experiments employing this model will evaluate the differential effects of NF1 
mutations on LGG formation and growth.
